BCL2 and cancer: Since the pro-survival BCL-2 proteins are involved in such a broad range of cancers and intervention with a BH3 mimetic would cause those cells to undergo programmed cell death, therapeutics targeting the pro-survival BCL-3’s hydrophobic groove with small molecule compounds as BH3 mimetics.